Non-inferiority Trial on Treatments in Early COVID-19

NCT05321394 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

536

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Sotrovimab
DRUG: Tixagevimab Cilgavimab
DRUG: Nirmatrelvir Ritonavir

Sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Collaborators

[object Object]
[object Object]